NCT04919291

Brief Summary

To compare the efficacy to different profiles, direct head-to-head studies had been conducted. In one previous review study revealed that TG LASIK provided patient with better uncorrected visual acuity (UCVA) than WFO LASIK and WFG LASIK. In recent previous contralateral eye studies also showed that TG LASIK induced less postoperative higher-order aberration than WFO LASIK. However, these studies included only low-to-moderate myopia patients, for patients with high myopia (spherical equivalent \> 6D), the effect of TG LASIK comparing with WFO LASIK had not been reported before. The aim of our study is to analyze and compare the visual performance of TG LASIK and WFO LASIK in high myopia and low-to-moderate myopia patients, , particularly UCVA, corrected distance visual acuity (CDVA), contrast sensitivity (CS), and wavefront aberration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 9, 2021

Completed
Last Updated

June 9, 2021

Status Verified

June 1, 2021

Enrollment Period

6 months

First QC Date

March 23, 2021

Last Update Submit

June 3, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Visual acuity

    uncorrected visual acuity and corrected distance visual acuity

    3 months after surgery

  • Corneal wavefront analysis

    horizontal coma aberration (Z 3,1), spherical aberration (Z 4,0), and trefoil aberration

    3-months postoperative visit

  • Contrast sensitivity

    4 spatial frequencies: 3, 6, 12, and 18 cycles per degree (cpd).

    3-months postoperative visit

  • Quality of vision questionnaire

    A 11-item questionnaire, item scores range from 0 to 10 and higher item scores in questionnaire indicated more difficulty in achieving specific visual tasks

    3-months postoperative visit

Study Arms (2)

Topoguided LASIK

ACTIVE COMPARATOR

Topoguided ablation profile on dominant eye

Device: Topoguided LASIK

Wavefront optimized LASIK

ACTIVE COMPARATOR

Wavefront optimized ablation profile on non-dominant eye

Device: Wavefront optimized LASIK

Interventions

Topoguided ablation profile on dominant eye

Topoguided LASIK

Wavefront optimized ablation profile on non-dominant eye

Wavefront optimized LASIK

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age between 20 and 50 years old
  • CDVA of both eyes could reach 0.1 logarithm of the minimum angle of resolution (logMAR)
  • stable refractive errors of myopia and astigmatism

You may not qualify if:

  • cataract
  • corneal opacities or irregularities
  • dry eye (Schirmer's test I ≤ 5mm)
  • amblyopia
  • coexisting ocular pathologies
  • glaucoma
  • non-dilating pupil
  • history of intraocular surgery, laser therapy, or retinopathy
  • optic nerve or macular diseases
  • estimated postoperative cornea residual stromal thickness less than 250 μm
  • pregnancy or under lactation
  • uncontrolled diabetic mellitus or systemic immune disease
  • refusal or unable to maintain follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Nobel Eye Clinic

Taipei, Taiwan

Location

Related Publications (7)

  • Sutton G, Lawless M, Hodge C. Laser in situ keratomileusis in 2012: a review. Clin Exp Optom. 2014 Jan;97(1):18-29. doi: 10.1111/cxo.12075. Epub 2013 Jun 21.

    PMID: 23786377BACKGROUND
  • Moreno-Barriuso E, Lloves JM, Marcos S, Navarro R, Llorente L, Barbero S. Ocular aberrations before and after myopic corneal refractive surgery: LASIK-induced changes measured with laser ray tracing. Invest Ophthalmol Vis Sci. 2001 May;42(6):1396-403.

    PMID: 11328757BACKGROUND
  • Schallhorn SC, Farjo AA, Huang D, Boxer Wachler BS, Trattler WB, Tanzer DJ, Majmudar PA, Sugar A; American Academy of Ophthalmology. Wavefront-guided LASIK for the correction of primary myopia and astigmatism a report by the American Academy of Ophthalmology. Ophthalmology. 2008 Jul;115(7):1249-61. doi: 10.1016/j.ophtha.2008.04.010.

    PMID: 18598819BACKGROUND
  • Stonecipher K, Parrish J, Stonecipher M. Comparing wavefront-optimized, wavefront-guided and topography-guided laser vision correction: clinical outcomes using an objective decision tree. Curr Opin Ophthalmol. 2018 Jul;29(4):277-285. doi: 10.1097/ICU.0000000000000495.

    PMID: 29787391BACKGROUND
  • Kim J, Choi SH, Lim DH, Yang CM, Yoon GJ, Chung TY. Topography-guided versus wavefront-optimized laser in situ keratomileusis for myopia: Surgical outcomes. J Cataract Refract Surg. 2019 Jul;45(7):959-965. doi: 10.1016/j.jcrs.2019.01.031. Epub 2019 Jun 10.

    PMID: 31196580BACKGROUND
  • Kim J, Choi SH, Lim DH, Yoon GJ, Chung TY. Comparison of outcomes after topography-modified refraction versus wavefront-optimized versus manifest topography-guided LASIK. BMC Ophthalmol. 2020 May 14;20(1):192. doi: 10.1186/s12886-020-01459-0.

    PMID: 32410588BACKGROUND
  • Ozulken K, Yuksel E, Tekin K, Kiziltoprak H, Aydogan S. Comparison of Wavefront-Optimized Ablation and Topography-Guided Contoura Ablation With LYRA Protocol in LASIK. J Refract Surg. 2019 Apr 1;35(4):222-229. doi: 10.3928/1081597X-20190304-02.

    PMID: 30984979BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dean, Nobel Eye Institute

Study Record Dates

First Submitted

March 23, 2021

First Posted

June 9, 2021

Study Start

September 26, 2019

Primary Completion

March 14, 2020

Study Completion

June 30, 2020

Last Updated

June 9, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations